MARKET

VRTX

VRTX

Vertex Pharmaceuticals Inc
NASDAQ
521.12
-7.78
-1.47%
After Hours: 520.25 -0.87 -0.17% 19:42 09/09 EDT
OPEN
524.00
PREV CLOSE
528.90
HIGH
528.17
LOW
520.08
VOLUME
958.51K
TURNOVER
--
52 WEEK HIGH
560.25
52 WEEK LOW
374.17
MARKET CAP
132.08B
P/E (TTM)
30.32
1D
5D
1M
3M
1Y
5Y
1D
Vertex (VRTX) Stock Still Looks Like A Bargain On Its 181% Run
Simply Wall St · 15h ago
JPMorgan Nasdaq Equity Premium Income ETF Experiences Big Inflow
NASDAQ · 16h ago
Vertex Pharmaceuticals: Solid Growth But Valuation Still Requires Flawless Execution
Seeking Alpha · 21h ago
Goldman Sachs Just Added Vertex Pharmaceuticals to Its Conviction List. Here's the Bull Case for the Big Biotech Stock
The Motley Fool · 1d ago
Where Will CRISPR Therapeutics Stock Be in 5 Years?
The Motley Fool · 1d ago
3 Market-Beating Stocks for Long-Term Investors
Barchart · 1d ago
Weekly Report: what happened at VRTX last week (0831-0904)?
Weekly Report · 2d ago
Healthcare August recap: Moderna jumps 156% as biotech shines; DaVita sinks
Seeking Alpha · 4d ago
More
About VRTX
Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The Company has approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia, acute pain and acromegaly, and it continues to advance clinical and research programs in these areas. It also has a clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including IgA nephropathy, neuropathic pain, APOL1-mediated kidney disease, primary membranous nephropathy, congenital adrenal hyperplasia, ACTH-dependent Cushing's syndrome, autosomal dominant polycystic kidney disease, type 1 diabetes, generalized myasthenia gravis, and myotonic dystrophy type 1. The Company's pipeline also includes PALSONIFY (paltusotine) and atumelnant. PALSONIFY is the once-daily oral therapy for acromegaly.

Webull offers Vertex Pharmaceuticals Inc stock information, including NASDAQ: VRTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VRTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VRTX stock methods without spending real money on the virtual paper trading platform.